Magnetic resonance imaging-guided transcatheter implantation of a prosthetic valve in aortic valve position: Feasibility study in swine by Kuehne, Titus et al.
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muccessful transcatheter aortic valve implantation in the aortic
alve position has been recently reported (1,2). However, implan-
ation remains challenging, and malpositioning of the device can
ead to a life-threatening situation. In contrast to conventional
-ray angiography, magnetic resonance imaging (MRI) provides
recise three-dimensional information about both soft tissue anat-
my and catheter position as well as immediate parameters of
ardiovascular function (3). The purpose of this study was to assess
he feasibility of MRI to guide transcatheter valve implantation in
he aortic valve position.
Self-expanding, non-covered nitinol stents of 20 mm diameter
Angiomed, Karlsruhe, Germany) were used as a carrier for a
rosthetic heart valve. A tricuspid valve was fabricated from a
.1-mm-thick polytetrafluoroethylene membrane (Impra, Phoe-
ix, Arizona) and sutured into the stent. The valved stent was
ompressed and front-loaded into a 10-F delivery system that
omprised a pig tail and a working lumen. For catheter visualiza-
ion during MRI, small ferromagnetic markers (size0.5 mm3)
ere mounted on the delivery system distally and proximally to the
oaded valved stent, comparable to radiopaque markers for con-
entional X-ray angiography.
Interventions were performed in pigs (n  7, weight  26  3
g) under general anesthesia (2% isoflurane). A 12-F dilator sheath
as placed, using Seldinger techniques, in the carotid (n  4) and
liac artery (n  3). Thereafter, animals were moved into a 1.5-T
R scanner (Intera, Philips Medical Systems, Best, the Nether-
ands).
Before intervention, phasic aortic blood flow was measured in
he ascending aorta using velocity encoded cine (VEC) MRI
repetition time [TR]  16 ms, echo time [TE]  9 ms, field of
iew [FOV]  200 to 350, matrix  256  256, phase encoding
elocity [Venc]  200 cm/s). A set of balanced fast field echo
bFFE) images was used to evaluate cardiovascular anatomy
ncluding the diameter of the aortic valve annulus and its distance
o the coronary artery orifices and the mitral valve. Left ventricular
LV) function (ejection fraction) and biventricular wall motion
ere assessed in a short-axis plane using standard protocols (TR
.7 ms, TE 1.4 ms, flip angle 50°, FOV 200 to 350, matrix
256  256, phases  20 to 25).
For implantation, the delivery system was advanced from the
ntroducer-sheath to the LV under MR fluoroscopy without
se of guide wires. The MR fluoroscopy was based on interactive
eal-time, steady-state, free processing sequences (TR  2.7 ms,
E  1.4 ms, FOV  200 to 350, matrix  144  144,
cquisition frame rate  10 frames/s; images were displayed
nline on an in-room monitor, and investigators had hearing
rotection). Coordinates of the susceptibility markers were taken
ntil the distal marker was seen 2 mm below the aortic valve
nnulus, and a set of multiphase bFFE images was used to confirm
nal catheter position. The release of the valved stent was finally
onitored under MR fluoroscopy. The aim was to implant the
nnulus of the prosthetic valve on top of the annulus of the native
ortic valve. iAfter implantation, the following parameters were assessed to
etermine the success of the intervention: 1) patency of the mitral
alve and coronary artery orifices; 2) LV function and biventricular
all motion using bFFE; and 3) phasic aortic blood flow within
he lumen of the valved stent using VEC MRI. Finally, the
osition and morphology of the valved stents were determined at
utopsy after the animals were euthanized with pentobarbital.
Paired Student t test was used to compare measurements made
efore and after the intervention and the MRI- and postmortem-
erived measurements.
All seven animals had successful implantation of a prosthetic
ortic valve without misplacement or cardiovascular trauma. The
verage duration of the MRI-guided intervention was 53  11
in. Preoperative, bFFE provided clear images for assessment of
ardiovascular anatomy (Fig. 1). The diameter of the aortic valve
nnulus was measured at systole with 17.4  2.1 mm and its
istance to the coronary artery orifices and the upper rim of the
itral valve with 10.5  2.8 mm and 8.2  2.7 mm, respectively.
t autopsy, measured diameters/distances were 17.8  3.1 mm,
1.1  3.4 mm, and 8.6  2.4 mm, respectively (p  0.9).
he ferromagnetic markers on the shaft of the delivery system
roduced a circumscript susceptibility artefact, which was easily
erceptible during MRI and enabled clear determination of the
osition of the loaded valved stent in relation to its surrounding
natomy (Fig. 1).
Susceptibility and radiofrequency shielding effects of the stent
llowed quick recognition of the valved stent during and after its
elivery but caused no image distortion of the adjacent anatomy
Figs. 1 and 2). After implantation, bFFE images demonstrated
he perfusion of the proximal coronary arteries (Fig. 2). Wall
otion abnormalities were not observed. The LV ejection fraction
s measured before and after valved stent implantation was 61 
% and 60  6%, respectively (p  0.8). Assessment of quanti-
ative blood flow with VEC MRI showed no aortic regurgitation
n five animals and mild central valve incompetence with a
egurgitant fraction of 8.2  3.1% in two cases (Fig. 2). There was
o evidence for aortic valve stenosis. Peak flow velocities as
easured within the lumen of the nitinol stent were 1.1 0.5 m/s
ompared with 1.0  0.7 m/s measured before the implantation
p  0.7). Unobstructed mitral valve leaflets were evidenced in all
xperiments (Fig. 2). Postmortem examination revealed accurate
mplantation of the prosthetic valve with a precision of 2.3  1.1
m and confirmed unobstructed coronary arteries (Fig. 2) and
itral valve leaflets.
The current study demonstrates that transcatheter implantation
f a prosthetic valve in the aortic valve position is feasible under
RI guidance. The MRI method features the advantage of
cquiring images that contain precise three-dimensional informa-
ion about both soft tissue anatomy and the interventional instru-
ent. Passive MRI catheter tracking by use of susceptibility
arkers enabled precise position monitoring of the interventionalnstrument. The 10-F delivery system was easy to control without
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2248 Correspondence JACC Vol. 44, No. 11, 2004
December 7, 2004:2247–58igure 1. Interactive real-time magnetic resonance image (upper panels) and balanced fast field echo (lower panels) of the heart (swine). Note the
usceptibility markers of the delivery system (small arrows in panels A, C, and D), the aortic valve (panel C), coronary arteries (panel D), and mitral valve
large arrow, panel A). Panel B shows the valved stent during delivery (large arrow).igure 2. (A) Balanced fast field echo image (bFFE) of implanted valved stent (large arrow) (swine). Note unobstructed mitral valve (small arrow). (B)
epresentative aortic phasic flow measured with velocity encoded cine MRI within the lumen of a valved stent without (solid line) and with (dotted line)
ild aortic insufficiency. (C and D) BFFE image of perfused proximal coronary arteries (arrows) and corresponding photography of the heart with probe
ithin coronary artery.
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December 7, 2004:2247–58uide wires. However, the development of guide wires suited for
nterventional MRI is warranted.
Preoperatively, MRI allowed noninvasive assessment of cardiovas-
ular anatomy and function. During and after implantation, the
osition of the prosthetic valve was easy to determine. Besides this
orphologic information, MRI provided immediate post-
ntervention physiologic parameters of cardiac function and perfusion
f the proximal course of the coronary arteries. In addition, VEC
RI demonstrated optimal function of the implanted prosthetic valve
n five cases and mild central valvular insufficiency in two cases.
In conclusion, the results of this study imply that MRI is a
romising tool for transcatheter placement of valved stents. How-
ver, further validation of safety aspects is needed in chronic
tudies with larger numbers of animals.
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Feasibility of Adjusting Paced Left Ventricular Activation
mulus Strengtho the Editor: Cardiac resynchronization therapy (CRT) im-
roves symptoms and decreases hospitalizations in selected pa-
ients with heart failure (1,2). With CRT, pacing from the left
entricle (LV) alters the ventricular activation (VA) sequence,
hanging the QRS morphology. In responders, change in VA
mproves cardiac filling and ejection (3). However, many patients
re nonresponders. The LV lead location is the major determinant
f paced activation but is often constrained by the location of
oronary sinus vein branches. During LV mapping for ventricular
achycardia, increased pacing stimulus strength (SS) has been
emonstrated to capture an enlarged myocardial area, producing a
arger “virtual electrode” (4). If the enlarged area of myocardial
apture extends beyond a discrete region of conduction block, the
S increase could result in VA change and more rapid conduction
o a remote location, such as the right ventricular (RV) apex.
We hypothesized that paced VA can be manipulated by
ncreasing SS. We expected activation changes to be more marked
hen pacing near areas of scarred or infarcted myocardium.
Ten patients with New York Heart Association functional class
I and III congestive heart failure, ejection fraction40%, referred
or ablation were enrolled according to protocols approved by the
righam and Women’s Hospital human subject protection com-
ittee.
Using an electroanatomic mapping system (CARTO, Biosense-
ebster Inc., Diamond Bar, California), three-dimensional plots
mean of 136  47 points per patient) of bipolar electrogram
mplitude were created (5). Endocardial LV mapping was per-
ormed with a 7-F steerable catheter (Biosense-Webster Inc.).
lectrograms were recorded on a separate digital system (Prucka
ngineering Inc., Houston, Texas). Epicardial mapping by percu-
aneous subxiphoid approach was performed in one patient.
atheter stability was confirmed by biplane fluoroscopy, the
apping system, and continuous monitoring of electrogram mor-Pacing at outputs of threshold, 5 mA, and 10 mA was
erformed at 6 to 10 separated LV sites. In one case, epicardial
acing at 20 mA was performed because of high pacing threshold
10 mA). The anode was in the inferior vena cava (IVC). A
uadripolar catheter at the RV apex was the reference catheter.
trial, ventricular, and His bundle electrograms were assessed to
xclude antegrade atrial conduction during pacing.
Stimulus to RV conduction times and stimulus to QRS con-
uction times (QRS latency) were measured from the stimulus
rtifact to the first bipolar peak of the electrogram from the RV
pical catheter and to the earliest VA in the surface electrocardio-
ram (ECG). Changes in QRS morphology with pacing were
efined as any of the following: QRS width change of 40 ms;
ew Q-, R-, or S-wave of 25% of the total QRS amplitude;
50% change in ratio of R or S components of QRS complex;
able 1. Parameters With Stimulus Strength Alteration
Total
Unchanged
QRS
Changed
QRS p Value†
acing sites 95 78 17
tim to RV (ms)
Threshold 118  62* 111 52* 150 93 0.0001
10 mA 95  43 96  43 87  44
RS duration (ms)
Threshold 199  39* 196 40‡ 213  28‡ 0.03
10 mA 192  43 191  37 195  31
RS latency (ms)
Threshold 47  52* 36 39‡ 99  73‡ 0.0001
10 mA 32  34 27  29 54  49
lectrogram amplitude
(mV)
2.0  2.0 2.3 2.1 0.8  1.1 0.007
p  0.001 for comparison of threshold with 10 mA stimulus strengths. †p value
eported for changed versus unchanged QRS. ‡p  0.05 for threshold versus 10 mA
timulus strengths.
RV  right ventricle.
